Genpact Limited (G) Receives Coverage Optimism Score of 0.12
Headlines about Genpact Limited (NYSE:G) have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Genpact Limited earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave media coverage about the business services provider an impact score of 47.0284863426757 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the headlines that may have impacted Accern’s analysis:
- Genpact : Senior Management Expects Humans and Robots to be Comfortable Coworkers by 2020, But Skills and Culture Gaps Pose Hurdles (4-traders.com)
- The Insight Partners Added “World Healthcare BPO Market Report 2017-2025” To Its Research Database. (emailwire.com)
- Middle East and Africa Healthcare BPO Market is poised to touch USD 14.12 Bn by 2020 | Market Data Forecast (medgadget.com)
- Asia Pacific Healthcare BPO Market is poised to touch USD 114.37 million by 2021 (pressbox.co.uk)
Several equities analysts have weighed in on the company. Cowen and Company restated an “outperform” rating and set a $33.00 price target (up previously from $30.00) on shares of Genpact Limited in a report on Thursday, August 3rd. Wedbush assumed coverage on Genpact Limited in a report on Thursday, August 3rd. They set a “neutral” rating and a $33.00 price target for the company. Zacks Investment Research upgraded Genpact Limited from a “hold” rating to a “buy” rating and set a $33.00 price target for the company in a report on Tuesday, August 8th. BMO Capital Markets raised their price target on Genpact Limited from $26.00 to $30.00 and gave the company a “market perform” rating in a report on Thursday, August 3rd. Finally, Deutsche Bank AG raised their price target on Genpact Limited from $26.00 to $28.00 and gave the company a “hold” rating in a report on Thursday, August 3rd. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Genpact Limited currently has an average rating of “Buy” and an average price target of $31.86.
Genpact Limited (NYSE:G) last announced its earnings results on Wednesday, August 2nd. The business services provider reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.10. Genpact Limited had a return on equity of 22.67% and a net margin of 10.30%. The business had revenue of $670.70 million during the quarter, compared to analysts’ expectations of $642.68 million. During the same quarter in the prior year, the firm earned $0.36 earnings per share. The business’s revenue was up 6.4% compared to the same quarter last year.
The company also recently announced a special dividend, which will be paid on Thursday, September 21st. Shareholders of record on Friday, September 8th will be issued a dividend of $0.06 per share. The ex-dividend date is Thursday, September 7th. This represents a dividend yield of 0.84%. Genpact Limited’s payout ratio is currently 18.05%.
In other Genpact Limited news, insider Mohit Thukral sold 25,000 shares of the stock in a transaction that occurred on Friday, August 25th. The stock was sold at an average price of $28.37, for a total transaction of $709,250.00. Following the completion of the transaction, the insider now owns 85,305 shares of the company’s stock, valued at $2,420,102.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Edward J. Fitzpatrick sold 57,934 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $28.54, for a total value of $1,653,436.36. Following the transaction, the chief financial officer now directly owns 113,520 shares of the company’s stock, valued at approximately $3,239,860.80. The disclosure for this sale can be found here. Insiders have sold 10,358,442 shares of company stock valued at $297,475,276 in the last three months. Insiders own 1.55% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Genpact Limited (G) Receives Coverage Optimism Score of 0.12” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.watchlistnews.com/genpact-limited-g-receives-coverage-optimism-score-of-0-12/1576790.html.
About Genpact Limited
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.